FDA Approves IV Antibiotic for Complicated UTIs

FDA Approves IV Antibiotic for Complicated UTIs

(MedPage Today) -- The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract infection (cUTI), including acute pyelonephritis, caused by susceptible Escherichia coli and Klebsiella pneumoniae...

FDA approves fosfomycin for treating cUTIs | Contemporary OB/GYN

The FDA has approved injectable fosfomycin for adults with complicated urinary tract infections, offering a new treatment option against multidrug-resistant bacteria.

FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections

The federal agency gave the nod to Meitheal Pharmaceuticals for its antibiotic, Contepo, an intravenous fosfomycin offering a new mechanism of action and a new option for adults with complicated urinary tract infections, including those caused by resistant Gram-negative pathogens.

FDA approves fosfomycin for complicated urinary tract infections

The approval is supported by the phase 2/3 ZEUS trial.